
Click the link below the picture
.
In 2022 Reuben Cheatem thought he had food poisoning—again. The painter and visual artist had first spotted blood in his stool the year before, and he assumed it was from repeated episodes of bad food poisoning. But this time the digestive issues, stomach pains and irregular bowel movements wouldn’t let up. After three weeks, he knew they weren’t the result of contaminated food or an everyday bug. His doctor thought he had diverticulitis, a type of colon inflammation, and prescribed antibiotics and pain medications. After a few months, the symptoms returned. Nothing worked. On “about my fourth trip to the ER and my fourth CT [computed tomography] scan, a specialist said there was no way that [this] was diverticulitis,” Cheatem says. “It was something further.”
Doctors found an advanced malignant tumor in Cheatem’s lower colon. That September, at age 42, he was diagnosed with stage III colorectal cancer, which set him on a path to surgery and chemotherapy.
He was completely thrown by the words coming out of the doctor’s mouth. Cheatem thought he was healthy; he ate healthily and exercised regularly, and in his artwork he even avoided using oil-based paints known to contain carcinogens. Plus, he had no family history of colorectal cancer. “The cancer diagnosis itself came as a shock because I felt like I had been taking so many steps to simply not get cancer,” says Cheatem, who now lives in Texas.
Stories like Cheatem’s are becoming more common as severe colorectal cancer rates rise among younger, traditionally low-risk people. And these cases have grown increasingly visible. Actors James Van Der Beek and Chadwick Boseman were both in their 40s when they died from the disease. The uptick in cases has some scientists wondering whether they’re dealing with an entirely new type of colorectal cancer. As they race to find clues to explain the disturbing trend, several theories are emerging.
Colorectal cancer is still far more common in adults older than age 65. What’s shifted is the frequency of cases: the rate among older adults has been declining, but the number of diagnoses in younger people has continued to escalate since the mid-1990s. In response to the trend, in 2021, the U.S. Preventive Services Task Force (USPSTF) lowered the recommended screening age from 50 to 45. In January 2026, the American Cancer Society’s annual report stated that colorectal cancer had officially become the deadliest cancer in people under age 50 in the U.S. Similar increases in rates of the cancer in younger age groups have been seen globally. People born in the 1990s have at least a fourfold-higher risk of developing colorectal cancer than those born in the 1960s in countries such as Australia, Canada and England. Health registries in Korea, Japan, Thailand and India have also reported increasing cases over the past several decades. Epidemiologists have noticed that the spike in incidence is tied to the time when a person was born, pointing toward generational shifts in risk or exposure.“Is this a completely new cancer that we’re now seeing in young people for whatever reason?” —Andrea Cercek Memorial Sloan Kettering Cancer CenterMost experts agree that the cause or causes won’t be clear-cut. Family history and genetics have been strongly associated with higher risk. But Kimmie Ng, an oncologist and leader in early-onset colorectal cancer research, and her team at the Dana-Farber Cancer Institute have seen not only an overall surge in cases in young people but more advanced-stage tumors in people who have no family history of cancer and are otherwise in good health, similar to Cheatem. Some research suggests that generational shifts in lifestyle, such as eating more processed foods and getting less physical activity, and environmental factors—including exposure to plastics and toxic chemicals—probably play some role
Unknown exposures in childhood or even in the womb could be factors, Ng says. Delays in getting tested may also explain part of it, she adds. A 2018 report found that 67 percent of people diagnosed with early-onset colorectal cancer went to at least two physicians before receiving that diagnosis. Ng suspects, however, that there is more to the mysterious trend. “Regardless of how they were diagnosed, the survival of the very youngest patients is still worse,” she says. “That suggests to me that there may be something biologically different.”
Johns Hopkins University oncologist Elizabeth Jaffee agrees that delays in diagnosis go only so far toward explaining the surge. “We don’t know what’s driving these [tumors] biologically yet, and that’s really the problem,” she says. “We need more biology to go along with all of this epidemiology and correlative studies.”
Every year, leading cancer experts flock to one of the biggest meetings in their field—the American Association of Cancer Research’s annual meeting. And increasingly, the phenomenon of early-onset colorectal cancer is a major topic of conversation. At the 2025 conference, Jaffee moderated a panel focused on the challenges facing colorectal cancer researchers and patients. Panelist and oncologist Andrea Cercek posed a query that has continued to weigh heavily on researchers and clinicians.
“Is this a completely new cancer that we’re now seeing in young people for whatever reason?” asked Cercek, co-director of the Center for Young Onset Colorectal and Gastrointestinal Cancer at Memorial Sloan Kettering Cancer Center. “Or [has there] just been this shift that’s now happening younger and younger?”
Cancer can be a slow, surreptitious illness—for decades researchers have called it a “disease of the aging.” Cells constantly turn over, and little mistakes—or mutations—can sneak into new batches. The body usually catches and eliminates these faulty cells, but with age, that process can slow down, and abnormal cells can pile up. “Mutation after mutation happens, and then it turns into a carcinoma,” Cercek told me.
Colorectal cancer typically follows a 10- to 15-year timeline from normal cell to small growth or polyp to, eventually, a larger mass or tumor. If mutant cells are not detected, they may amass over decades in older adults. Cercek and other researchers are investigating whether something might accelerate the timeline in people who develop the disease at a younger age.
Genetically, colorectal tumors look surprisingly similar in young and old bodies, involving roughly the same groups of mutations. In 2021 Cercek’s team found that tumors from people as young as age 14 and as old as age 93 showed no significant genetic differences. But how those mutations occur in the first place could explain why the tumors pop up earlier in some people.
“Babies or young kids or adolescents [could be] exposed to something in the environment that leads to some biological changes early in life that then predispose them to the development of cancer at a younger age than we have historically seen,” says Ng, who leads the Young-Onset Colorectal Cancer Center at Dana-Farber. “I do think that it is key to try to study early-life factors, though it’s really hard to do.”
.

Luisa Jung
.
.
Click the link below for the complete article:
.
__________________________________________
Leave a Reply